Singular Genomics Systems, Inc.
OMICDelisted Feb 21, 2025- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001850906
Singular Genomics Systems, Inc. was delisted on Feb 21, 2025; its insiders filed their last Form 4 on Feb 27, 2025; 20 institutions reported holding it in 13F filings for Q4 2024, worth $21.5M in total; no superinvestor held it.
13F holders, Q4 2023
Institutional positions in Singular Genomics Systems, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- −1 vs. Q3 2023
- Shares held
- 26.2M
- −806.1K (−3.0%) vs. Q3 2023
- Total value
- $12.1M
- +$1.53M (+14.5%) vs. Q3 2023
- New holders
- 5
- 8 more added
- Sold out
- 6
- 14 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OMIC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $512.7K |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 20 | $21.5M |
| Q3 2024 | 22 | $18.4M |
| Q2 2024 | 24 | $6.00M |
| Q1 2024 | 42 | $13.1M |
| Q4 2023 | 47 | $12.1M |
| Q3 2023 | 48 | $10.6M |
| Q2 2023 | 62 | $27.3M |
| Q1 2023 | 66 | $43.4M |
| Q4 2022 | 81 | $74.8M |
| Q3 2022 | 74 | $100.5M |
| Q2 2022 | 76 | $149.1M |
| Q1 2022 | 69 | $258.7M |
| Q4 2021 | 62 | $450.2M |
| Q3 2021 | 52 | $312.4M |
| Q2 2021 | 52 | $757.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Singular Genomics Systems, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 522 | $0 | 0.00% | +330+171.9% | Added |
| Citigroup Inc | 29 | $13 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 172 | $79 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 377 | $173 | 0.00% | +20+5.6% | Added |
| Qube Research & Technologies Ltd | 682 | $314 | 0.00% | −8,557−92.6% | Reduced |
| Rhumbline Advisers | 1,662 | $764 | 0.00% | 00.0% | Unchanged |
| DAGCO, Inc. | 1,700 | $782 | 0.00% | +1,700 | New |
| Dynamic Wealth Strategies, LLC | 1,700 | $782 | 0.00% | +1,700 | New |
| Royal Bank of Canada | 2,804 | $1.00K | 0.00% | +220+8.5% | Added |
| Tower Research Capital LLC (TRC) | 6,835 | $3.14K | 0.00% | −26,203−79.3% | Reduced |
| Morgan Stanley | 8,733 | $4.02K | 0.00% | −5,129−37.0% | Reduced |
| Bank of America Corp | 10,706 | $4.92K | 0.00% | −4,366−29.0% | Reduced |
| Barclays PLC | 12,284 | $5.65K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 12,558 | $5.78K | 0.00% | +12,558 | New |
| Bay Rivers Group | 14,000 | $6.44K | 0.00% | 00.0% | Unchanged |
| Engineers Gate Manager LP | 15,041 | $6.92K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 20,639 | $9.50K | 0.00% | −36−0.2% | Reduced |
| DLK Investment Management, LLC | 25,000 | $11.5K | 0.01% | +25,000 | New |
| Bank of New York Mellon Corp | 25,543 | $11.8K | 0.00% | 00.0% | Unchanged |
| Cambridge Investment Research Advisors, Inc. | 26,350 | $12.0K | 0.00% | 00.0% | Unchanged |
| Marino, Stram & Associates LLC | 40,000 | $18.4K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 46,072 | $21.2K | 0.00% | −17,750−27.8% | Reduced |
| JPMorgan Chase & Co | 51,786 | $23.8K | 0.00% | −9,719−15.8% | Reduced |
| XTX Topco Ltd | 56,261 | $25.9K | 0.01% | +56,261 | New |
| Northern Trust Corp | 80,363 | $37.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 112,615 | $51.8K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 117,860 | $54.2K | 0.00% | −593,993−83.4% | Reduced |
| Squarepoint Ops LLC | 120,083 | $55.3K | 0.00% | −14,113−10.5% | Reduced |
| Bridgeway Capital Management, LLC | 121,500 | $55.9K | 0.00% | −156,000−56.2% | Reduced |
| Weil Company, Inc. | 138,202 | $63.6K | 0.03% | +20,000+16.9% | Added |
| Renaissance Technologies LLC | 151,450 | $70.0K | 0.00% | −2,170−1.4% | Reduced |
| Hongkou Capital LP | 194,731 | $89.6K | 0.62% | 00.0% | Unchanged |
| Tikvah Management LLC | 316,854 | $145.8K | 0.05% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 418,322 | $193.0K | 0.00% | +150,000+55.9% | Added |
| Geode Capital Management, LLC | 460,639 | $212.0K | 0.00% | 00.0% | Unchanged |
| Verition Fund Management LLC | 475,000 | $218.5K | 0.00% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 540,697 | $248.8K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 833,595 | $383.5K | 0.00% | −32,491−3.8% | Reduced |
| Bank of Montreal | 982,499 | $481.4K | 0.00% | +396,561+67.7% | Added |
| Casdin Capital, LLC | 1,323,885 | $609.1K | 0.06% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,872,582 | $861.6K | 0.00% | −19,503−1.0% | Reduced |
| FMR LLC | 2,119,635 | $975.2K | 0.00% | +200.0% | Added |
| Perceptive Advisors LLC | 2,126,893 | $978.6K | 0.02% | −236,321−10.0% | Reduced |
| UBS Group AG | 2,209,350 | $1.02M | 0.00% | 00.0% | Unchanged |
| QVIDTVM Management LLC | 2,319,643 | $1.07M | 0.90% | +1,131,266+95.2% | Added |
| ARCH Venture Management, LLC | 3,798,926 | $1.75M | 1.07% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 4,984,871 | $2.29M | 0.04% | 00.0% | Unchanged |
| Acuitas Investments, LLC | 0 | $0 | 0.00% | −521,876−100.0% | Sold out |
| Platinum Investment Management Ltd | 0 | $0 | 0.00% | −427,444−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −358,676−100.0% | Sold out |
| Marquette Asset Management, LLC | 0 | $0 | 0.00% | −102,950−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −51,441−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −12,977−100.0% | Sold out |